Compare BN Agrochem with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 6.57%
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.29 times
With ROE of 7.3, it has a Very Expensive valuation with a 6.8 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0% of the company
Stock DNA
Trading & Distributors
INR 3,152 Cr (Small Cap)
92.00
22
0.00%
0.08
7.32%
7.13
Total Returns (Price + Dividend) 
BN Agrochem for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Below All Moving Averages and Now at Lower Circuit: BN Agrochem Ltd Loses 4.99% in a Single Session
At Rs 322.4, sellers queued relentlessly while buyers remained absent, forcing BN Agrochem Ltd to lock at its lower circuit limit of 4.99% on 3 Jun 2026. This freeze in price reflects unfilled supply overwhelming demand, with the exchange's 5% price band capping the day's losses.
Read full news articleAre BN Agrochem Ltd latest results good or bad?
BN Agrochem Ltd's latest financial results for Q4 FY26 reveal a complex picture of operational performance. The company reported net sales of ₹261.36 crores, reflecting a year-on-year growth of 22.02%. This marks a significant increase compared to the previous year's sales. However, the net profit for the same quarter was ₹2.95 crores, which represents a substantial decline of 84.68% year-on-year, highlighting a stark contrast between revenue growth and profitability. The operating margin for Q4 FY26 was recorded at 1.62%, a notable recovery from a negative margin of -18.93% in the same quarter last year. Despite this improvement, the profit after tax (PAT) margin fell to 1.13%, down from 8.99% year-on-year, indicating ongoing pressure on the company's pricing power and cost structure. Sequentially, the results show a recovery from the previous quarter, where the company faced a net loss of ₹6.78 crores i...
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Meeting Updates
29-May-2026 | Source : BSEPursuant to Regulation 30 of SEBI LODR 2015 please find attached decisions taken by Board of Directors in their meeting held today.
Results- Financial Results For March 31 2026
29-May-2026 | Source : BSEThe Board of directors in their meeting held today considered and approved the financial results (Standalone and Consolidated) for the year ended March 31 2026.
Compliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSEPursuant Regulation 24 A of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 please find attached Annual Secretarial Compliance Report for the year ended March 31 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (0.0%)
Anubhav Agarwal (5.93%)
Global Focus Fund (18.34%)
3.24%
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 22.02% vs 2,921.02% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -84.68% vs 2,215.38% in Mar 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 599.34% vs -692.71% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 618.05% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 1,158.87% vs 211.71% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 191.67% vs 4,122.99% in Mar 2025
YoY Growth in year ended Mar 2026 is 73.94% vs 731.31% in Mar 2025







